日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgery

采用伊匹木单抗和纳武单抗治疗(伴或不伴前期综合立体定向放射外科手术)的黑色素瘤脑转移患者的预后

Kleber, Troy J; Milton, Denái R; Srinivasan, Subhiksha; Panthi, Bikash; Floyd, Warren; Goethe, Eric A; Davies, Michael A; Tawbi, Hussein A; Glitza Oliva, Isabella C; Kaya, Diana; Li, Jing; Swanson, Todd A; Perni, Subha; Tom, Martin C; Wang, Chenyang; Prabhu, Sujit; Weinberg, Jeffrey S; McCutcheon, Ian E; Chung, Caroline; Ferguson, Sherise D; Beckham, Thomas H

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma

长期生存率和生物标志物分析评估新辅助联合辅助治疗瑞拉利单抗(抗LAG3)和纳武利尤单抗(抗PD-1)在可切除黑色素瘤患者中的疗效

Burton, Elizabeth M; Milton, Denái R; Tetzlaff, Michael T; Wani, Khalida; Ross, Merrick I; Postow, Michael A; Lazcano, Rossana; Glitza, Isabella C; Wong, Michael K; Patel, Sapna P; Diab, Adi; Gershenwald, Jeffrey E; McQuade, Jennifer L; Betof Warner, Allison; Prieto, Victor G; Lee, Jeffrey E; Goepfert, Ryan P; Fisher, Sarah B; Song, Addison; Malke, Jared; Simon, Julie M; Ariyan, Charlotte; Torres-Cabala, Carlos A; Davies, Michael A; Lazar, Alexander; Wargo, Jennifer A; Tawbi, Hussein A; Amaria, Rodabe N

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols

癌症免疫治疗学会 (SITC) 关于免疫治疗临床方案关键生物标志物的共识声明

Cottrell, Tricia R; Lotze, Michael T; Ali, Alaa; Bifulco, Carlo B; Capitini, Christian M; Chow, Laura Q M; Cillo, Anthony R; Collyar, Deborah; Cope, Leslie; Deutsch, Julie Stein; Dubrovsky, Genia; Gnjatic, Sacha; Goh, Denise; Halabi, Susan; Kohanbash, Gary; Maecker, Holden T; Maleki Vareki, Saman; Mullin, Sarah; Seliger, Barbara; Taube, Janis; Vos, Wim; Yeong, Joe; Anderson, Kristin G; Bruno, Tullia C; Chiuzan, Codruta; Diaz-Padilla, Ivan; Garrett-Mayer, Elizabeth; Glitza Oliva, Isabella C; Grandi, Paola; Hill, Elizabeth G; Hobbs, Brian P; Najjar, Yana G; Pettit Nassi, Phyllis; Simons, Virgil H; Subudhi, Sumit K; Sullivan, Ryan J; Takimoto, Chris H

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study

妊娠期晚期黑色素瘤:一项回顾性、多中心、基于登记研究的建议

Borgers, Jessica S W; Johnson, Douglas B; Livingstone, Elisabeth; Schadendorf, Dirk; Buchbinder, Elizabeth I; Haydu, Lauren E; Gohil, Laura; Robinson, William A; Mehmi, Inderjit; Hamid, Omid; Ferreira, Michelle; Salama, April K S; Dimitriou, Florentia; Carlino, Matteo S; Long, Georgina V; Ascierto, Paolo A; Simeone, Ester; Najjar, Yana G; Hospers, Geke A P; Choi, Jacob; Chandra, Sunandana; Wayne, Jeffrey D; García, Carlos I R; Xu, Wen; Lebbé, Céleste; Da-Meda, Laetitia; Atkinson, Victoria; Mckean, Meredith; Forschner, Andrea; Asare, Elliot A; Daletzakis, Antonios; Taylor, Jolyn S; Amant, Frédéric; Tsai, Katy K; Eroglu, Zeynep; Haanen, John B A G; Glitza de Oliva, Isabella C

Conjunctival melanoma genomic analysis reveals intermediate tumor mutation burden and genomic overlap with cutaneous melanoma.

结膜黑色素瘤基因组分析显示,其肿瘤突变负荷处于中间水平,并且与皮肤黑色素瘤存在基因组重叠。

Dimitriou Florentia, Wu Xiaogang, Nagarajan Priyadharsini, Glitza Isabella C, Zhao Li, Ning Jing, Patel Sapna P, Wargo Jennifer A, Futreal Andrew, Woodman Scott, McQuade Jennifer L, Esmaeli Bita

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

转移性黑色素瘤患者的淋巴细胞清除、肿瘤浸润淋巴细胞、高剂量与低剂量IL-2联合帕博利珠单抗治疗

Hasanov, Merve; Kiany, Simin; Forget, Marie-Andrée; Bassett, Roland; Davies, Michael A; Diab, Adi; Gershenwald, Jeffrey E; Glitza, Isabella C; Lee, Jeffrey E; Lucci, Anthony; McQuade, Jennifer L; Patel, Sapna P; Ross, Merrick I; Tawbi, Hussein A; Wargo, Jennifer A; Wong, Michael K; Bernatchez, Chantale; Hwu, Patrick; Haymaker, Cara; Amaria, Rodabe N

Proceedings of the seventh annual Women in Melanoma Conference

第七届年度女性黑色素瘤大会论文集

Najjar, Yana G; Orloff, Marlana; Mitchell, Tara C; Bowles, Tawnya L; Betof Warner, Allison; Bollin, Kathryn; Chandra, Sunandana; Cohen, Justine V; Eroglu, Zeynep; Funchain, Pauline; Gaughan, Elizabeth; Glitza Oliva, Isabella; Hsu, Sherry; Hu-Lieskovan, Siwen; Kennedy, Lucy Boyce; Truong, Thach-Giao; McKean, Meredith; Mehnert, Janice; Moon, Helen; Tsai, Katy K; Wilson, Melissa; Tran, Thuy; Buchbinder, Elizabeth I; Fecher, Leslie A; Guild, Samantha; Patel, Sapna P

Preclinical models of melanoma leptomeningeal disease to assess intrathecal checkpoint blockade

利用黑色素瘤软脑膜疾病的临床前模型评估鞘内检查点阻断

Guerrieri, Renato A; Fischer, Grant M; Cortez, Jacob R; Knighton, Barbara G; Ledesma, Debora A; Hudgens, Courtney W; Delcid, Yimmy F; Hu, Qianghua; Onana, Christian Y B; Carapeto, Fernando C L; Tezlaff, Michael T; Huse, Jason T; Hwu, Patrick; Burton, Elizabeth M; Glitza Oliva, Isabella C; Davies, Michael A; Ferguson, Sherise D

DDEL-15. EnTrega CSF circulation and drug delivery system improves drug distribution in brain parenchyma

DDEL-15. EnTrega脑脊液循环和药物输送系统改善脑实质中的药物分布

Majeed, Bushra; David, Jummy Funke; Bragazzi, Nicola Luigi; McCarthy, Zack; Grunnill, Martin David; Heffernan, Jane; Wu, Jianhong; Woldegerima, Woldegebriel Assefa; Kumthekar, Priya; Schwartz, Margaret; Nagpal, Seema; Glitza, Isabella; Forsyth, Peter; Sonabend, Adam Sonabend; Ruiz, Ernesto; Kalish, Kevin; DePasqua, Anthony; Gormley, William; Glicksman, Marcie

Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial

Selinexor (KPT-330) 联合免疫检查点抑制剂治疗葡萄膜黑色素瘤:一项 1B 期试验

Gouda, Mohamed A; Zarifa, Abdulrazzak; Yang, Yali; Stephen, Bettzy; Gurses, Serdar A; Sprenger, Ashabari; Tian, Yanyan; Derbala, Mohamed H; Oliva, Isabella Glitza; Meric-Bernstam, Funda; Patel, Sapna P